Limited coverage drugs – sodium phenylbutyrate
Last updated on December 14, 2022|
Generic name |
sodium phenylbutyrate |
|---|---|
|
Strength |
483 mg/g |
|
Form |
oral granules |
|
Special Authority criteria |
Approval period |
|---|---|
|
For the chronic management of urea cycle disorders (UCD) |
1 year |
Practitioner exemptions
- A collaborative prescribing agreement (CPA) is available to a limited number of practitioners specializing in the chronic management of UCD who are working in a designated metabolic disease clinic.
Special notes
- None
Special Authority requests
- Special Authority requests are not required.